1596-1

Y-27632, dihydrochloride

465.00 €

1596-5

Y-27632, dihydrochloride

983.40 €

1596-50

Y-27632, dihydrochloride

4594.20 €

HY-10071

Y-27632

Y-27632 is an orally active, ATP-competitive inhibitor of ROCK-I and ROCK-II, with Kis of 220 and 300 nM, respectively. Y-27632 attenuates Doxorubicin-induced apoptosis of human cardiac stem cells. Y-27632 also suppresses dissociation-induced apoptosis of murine prostate stem/progenitor cells. Y-27632 primes human induced pluripotent stem cells (hIPSCs) to selectively differentiate towards mesendodermal lineage via epithelial-mesenchymal transition-like modulation[1][2][3][4][5][6][7].

1558.53 €

E1KS1049

Y-27632

466.80 €

MBS515044-25mg

Y-27632

816.12 €